Johannes Fruehauf is a founder and the president and executive director of LabCentral. A physician and biotech entrepreneur, prior to LabCentral he founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. He is also a co-founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits. Fruehauf earned his medical degree at the University of Frankfurt and his PhD at the University of Heidelberg (Germany).